Dana-Farber Researchers Set to Showcase Two Plenary Studies and Groundbreaking Late-Breaking Cancer Research at 2026 ASCO
In a landmark event set to unfold at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) ...
In a landmark event set to unfold at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) ...
In a remarkable stride toward understanding the enigmatic rise of colorectal cancer among younger adults, researchers at the Dana-Farber Cancer ...
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research ...
In a significant leap forward for the management of a perplexing blood cancer precursor, researchers at Dana-Farber Cancer Institute in ...
In a groundbreaking advancement for the treatment of central nervous system (CNS) lymphoma, the U.S. Food and Drug Administration (FDA) ...
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial, ...
In a groundbreaking advancement in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking advancement poised to revolutionize acute leukemia diagnosis and treatment, researchers at the Dana-Farber Cancer Institute have unveiled ...
A groundbreaking new analysis from Dana-Farber Cancer Institute highlights a significant link between diet, physical activity, and survival outcomes in ...
A groundbreaking clinical study spearheaded by researchers at the Dana-Farber Cancer Institute in Boston is embarking on an innovative quest ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine